Company · CIK 1956827
Abivax S.A.
| CIK | 1956827 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | I0 |
| Listed | ABVX (Nasdaq), AAVXF (OTC) |
| First annual or quarterly report | 2024-04-05 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-283336 | 2024-11-19 | 2024-11-26 | 2 | |
| 333-274780 | 2023-09-29 | 2023-10-23 | 5 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-02 | 424B5Shelf takedown | 333-288884 | 0001193125-26-294491 |
| 2026-06-30 | 424B5Shelf takedown | 333-288884 | 0001193125-26-290817 |
| 2025-07-24 | 424B5Shelf takedown | 333-288884 | 0001193125-25-164456 |
| 2025-07-23 | 424B5Shelf takedown | 333-288884 | 0001193125-25-163478 |
| 2024-11-26 | EFFECTDeclared effective | 333-283336 | 9999999995-24-003594 |
| 2024-11-19 | F-3Shelf registered | 333-283336 | 0001193125-24-261713 |
| 2023-10-23 | 424B4Final prospectus | 333-274780 | 0001193125-23-260833 |
| 2023-10-19 | EFFECTDeclared effective | 333-274845 | 9999999995-23-003017 |
| 2023-10-19 | EFFECTDeclared effective | 333-274780 | 9999999995-23-003016 |
| 2023-10-18 | F-1/AAmendment | 333-274780 | 0001193125-23-258642 |
| 2023-10-16 | F-1/AAmendment | 333-274780 | 0001193125-23-256667 |
| 2023-09-29 | F-1Registration filed | 333-274780 | 0001193125-23-247378 |
| 2022-12-16 | DRSDraft made public | 377-06511 | 0000950123-22-012666 |